An update on the management of urinary tract infections in the era of antimicrobial resistance

MS Bader, M Loeb, AA Brooks - Postgraduate medicine, 2017 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …

Antibiotic resistant superbugs: assessment of the interrelationship of occurrence in clinical settings and environmental niches

AA Adegoke, AC Faleye, G Singh, TA Stenström - Molecules, 2016 - mdpi.com
The increasing threat to global health posed by antibiotic resistance remains of serious
concern. Human health remains at higher risk due to several reported therapeutic failures to …

Febrile urinary-tract infection due to extended-spectrum beta-lactamase–producing Enterobacteriaceae in children: A French prospective multicenter study

F Madhi, C Jung, S Timsit, C Levy, S Biscardi… - PLoS …, 2018 - journals.plos.org
Objectives To assess the management of febrile urinary-tract infection (FUTIs) due to
extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-E) in children, the …

Extended Spectrum Beta‐Lactamase (ESBL) Produced by Gram‐Negative Bacteria in Trinidad and Tobago

PE Akpaka, A Vaillant, C Wilson… - International Journal of …, 2021 - Wiley Online Library
Gram‐negative bacterial infections are a global health problem. The production of beta‐
lactamase is still the most vital factor leading to beta‐lactam resistance. In Trinidad and …

Preliminary survey of extended-spectrum β-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran

S Yazdansetad, MK Alkhudhairy, R Najafpour… - Heliyon, 2019 - cell.com
Infections caused by extended-spectrum β-lactamases (ESBLs) producing bacteria,
including Klebsiella pneumoniae have increasingly subjected to therapeutic limitations and …

Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

A Maharjan, A Bhetwal, S Shakya, D Satyal… - Infection and drug …, 2018 - Taylor & Francis
Background: Fecal carriage of multidrug-resistant and extended-spectrum β-lactamase
(ESBL)-producing Enterobacteriaceae is one of the important risk factors for infection with …

Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination …

Q Ni, Y Tian, L Zhang, C Jiang, D Dong, Z Li… - … and Infectious Disease, 2016 - Elsevier
Objectives To characterize extended-spectrum β-lactamase (ESBL)-producing Escherichia
coli isolates from the community, determine their antibiotic sensitivity profiles and quinolone …

Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: A prospective pilot study

E Demonchy, J Courjon, E Ughetto, M Durand… - International journal of …, 2018 - Elsevier
The emergence of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E)
infections requires re-assessment of therapeutic choices. Here we report the efficacy of …

How should we treat hospital-acquired and ventilator-associated pneumonia caused by extended-spectrum β-lactamase–producing Enterobacteriaceae?

JF Timsit, B Pilmis, JR Zahar - Seminars in Respiratory and …, 2017 - thieme-connect.com
Hospital-acquired and ventilator-associated pneumonia (HAP/VAP) due to extended-
spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) represent a growing …

[HTML][HTML] Clinical outcomes of carbapenem de-escalation regardless of microbiological results: a propensity score analysis

S Sadyrbaeva-Dolgova, P Aznarte-Padial… - International Journal of …, 2019 - Elsevier
Objective The aim of this study was to evaluate the safety and efficacy of de-escalation in
patients under treatment with carbapenems and its impact on clinical outcomes. Methods A …